Literature DB >> 29116189

Tobacco papers and tobacco industry ties in regulatory toxicology and pharmacology.

Clayton Velicer1, Gideon St Helen1,2,3,4, Stanton A Glantz5,6,7,8.   

Abstract

We examined the relationship between the tobacco industry and the journal Regulatory Toxicology and Pharmacology (RTP) using the Truth Tobacco Industry Documents Library and internet sources. We determined the funding relationships, and categorised the conclusions of all 52 RTP papers on tobacco or nicotine between January 2013 and June 2015, as "positive", "negative" or "neutral" for the tobacco industry. RTP's editor, 57% (4/7) of associate editors and 37% (14/38) of editorial board members had worked or consulted for tobacco companies. Almost all (96%, 50/52) of the papers had authors with tobacco industry ties. Seventy-six percent (38/50) of these papers drew conclusions positive for industry; none drew negative conclusions. The two papers by authors not related to the tobacco industry reached conclusions negative to the industry (p < .001). These results call into question the confidence that members of the scientific community and tobacco product regulators worldwide can have in the conclusions of papers published in RTP.

Entities:  

Keywords:  Conflict of interest; Journal bias; Regulatory policy; Tobacco industry

Mesh:

Year:  2017        PMID: 29116189      PMCID: PMC5775030          DOI: 10.1057/s41271-017-0096-6

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  24 in total

1.  Environmental tobacco smoke research published in the journal Indoor and Built Environment and associations with the tobacco industry.

Authors:  David Garne; Megan Watson; Simon Chapman; Fiona Byrne
Journal:  Lancet       Date:  2005 Feb 26-Mar 4       Impact factor: 79.321

2.  Why review articles on the health effects of passive smoking reach different conclusions.

Authors:  D E Barnes; L A Bero
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

3.  Comparison of select analytes in aerosol from e-cigarettes with smoke from conventional cigarettes and with ambient air.

Authors:  Rana Tayyarah; Gerald A Long
Journal:  Regul Toxicol Pharmacol       Date:  2014-10-24       Impact factor: 3.271

4.  TSNA exposure from cigarette smoking: 18 years of urinary NNAL excretion data.

Authors:  Scott Appleton; Raquel M Olegario; Peter J Lipowicz
Journal:  Regul Toxicol Pharmacol       Date:  2013-08-03       Impact factor: 3.271

5.  Influence of design characteristics on the outcome of retrospective cohort studies.

Authors:  G M Swaen; J M Meijers
Journal:  Br J Ind Med       Date:  1988-09

6.  Source of funding and outcome of clinical trials.

Authors:  R A Davidson
Journal:  J Gen Intern Med       Date:  1986 May-Jun       Impact factor: 5.128

7.  A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis.

Authors:  P A Rochon; J H Gurwitz; R W Simms; P R Fortin; D T Felson; K L Minaker; T C Chalmers
Journal:  Arch Intern Med       Date:  1994-01-24

8.  The p53 tumour suppressor gene and the tobacco industry: research, debate, and conflict of interest.

Authors:  Asaf Bitton; Mark D Neuman; Joaquin Barnoya; Stanton A Glantz
Journal:  Lancet       Date:  2005 Feb 5-11       Impact factor: 79.321

9.  Changes in levels of biomarkers of exposure observed in a controlled study of smokers switched from conventional to reduced toxicant prototype cigarettes.

Authors:  Christopher J Shepperd; Alison Eldridge; Oscar M Camacho; Kevin McAdam; Christopher J Proctor; Ingo Meyer
Journal:  Regul Toxicol Pharmacol       Date:  2013-03-25       Impact factor: 3.271

10.  TSNA levels in machine-generated mainstream cigarette smoke: 35 years of data.

Authors:  Scott Appleton; Raquel M Olegario; Peter J Lipowicz
Journal:  Regul Toxicol Pharmacol       Date:  2013-04-02       Impact factor: 3.271

View more
  1 in total

1.  Heat-not-burn tobacco products: a systematic literature review.

Authors:  Erikas Simonavicius; Ann McNeill; Lion Shahab; Leonie S Brose
Journal:  Tob Control       Date:  2018-09-04       Impact factor: 7.552

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.